Literature DB >> 19726058

Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells.

Axel Denz1, Christian Pilarsky, Daniela Muth, Felix Rückert, Hans-Detlev Saeger, Robert Grützmann.   

Abstract

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the eighth most common cancer with the lowest overall 5-y relative survival rate. Gene expression profiling of PDAC revealed an overexpression of the macrophage migration inhibitory factor (MIF), a lymphokine involved in cell-mediated immunity and inflammation, as well as in the regulation of cellular signal transduction.
MATERIALS AND METHODS: Endogenous MIF expression was silenced by treatment of pancreatic cancer cell lines using two independent MIF siRNAs. The expression of MIF RNA and protein after siRNA treatment was investigated using quantitative RT-PCR and Western blot. Induction of apoptosis was analyzed using fluorescence activated cell sorting (FACS).
RESULTS: Transfection of MiaPaCa-2 cells with MIF siRNA resulted in a reduction of MIF RNA and protein levels by more than 85%. After treatment, we observed an inhibition of cellular proliferation accompanied by induction of apoptosis. Analysis of the phosphorylation state of Akt showed a markedly increase of the phosphorylation at the Thr308 residue.
CONCLUSIONS: Using post-transcriptional silencing with small interfering RNAs, we could show that MIF acts as an autocrine growth factor involved in cell cycle progression. Since MIF is a secreted protein, a therapy directed against MIF or its receptor might lead to a significant growth reduction of PDAC. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726058     DOI: 10.1016/j.jss.2009.03.048

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  24 in total

1.  Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.

Authors:  Justin M M Cates; David B Friedman; Erin H Seeley; William D Dupont; Herbert S Schwartz; Ginger E Holt; Richard M Caprioli; Pampee P Young
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

Authors:  Naotake Funamizu; Chaoxin Hu; Curtis Lacy; Aaron Schetter; Geng Zhang; Peijun He; Jochen Gaedcke; Michael B Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Jeffrey Subleski; Tim Chan; Jonathan M Weiss; Timothy C Back; Katsuhiko Yanaga; Nader Hanna; H Richard Alexander; Anirban Maitra; S Perwez Hussain
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

Review 3.  Beta cell function: the role of macrophage migration inhibitory factor.

Authors:  Ivana Stojanovic; Tamara Saksida; Stanislava Stosic-Grujicic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

4.  Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.

Authors:  Sonja Djudjaj; Ina V Martin; Eva M Buhl; Nina J Nothofer; Lin Leng; Marta Piecychna; Jürgen Floege; Jürgen Bernhagen; Richard Bucala; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 10.121

5.  Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Authors:  James M Harper; J Erby Wilkinson; Richard A Miller
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

6.  MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.

Authors:  Akinobu Ochi; Dong Chen; Wibke Schulte; Lin Leng; Nickolas Moeckel; Marta Piecychna; Luisa Averdunk; Christian Stoppe; Richard Bucala; Gilbert Moeckel
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-24

7.  A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

Authors:  Shouhui Yang; Peijun He; Jian Wang; Aaron Schetter; Wei Tang; Naotake Funamizu; Katsuhiko Yanaga; Tadashi Uwagawa; Abhay R Satoskar; Jochen Gaedcke; Markus Bernhardt; B Michael Ghadimi; Matthias M Gaida; Frank Bergmann; Jens Werner; Thomas Ried; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

8.  A newly identified mechanism involved in regulation of human mesenchymal stem cells by fibrous substrate stiffness.

Authors:  Huihua Yuan; Yaxian Zhou; Ming-Song Lee; Yanzhong Zhang; Wan-Ju Li
Journal:  Acta Biomater       Date:  2016-06-28       Impact factor: 8.947

9.  The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model.

Authors:  Sebastian Kobold; Melanie Merk; Luisa Hofer; Philip Peters; Richard Bucala; Stefan Endres
Journal:  Oncotarget       Date:  2014-01-15

10.  Macrophage-tumor cell fusions from peripheral blood of melanoma patients.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Yuka Imamura-Kawasawa; Zhen Du; Diane M Thiboutot; Klaus F Helm; Rogerio I Neves; Thomas Abraham
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.